Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study

<div>Duration of the immediate post-cBTKi line of therapy (<i>n</i> = 352). Abbreviations: cBTKi = covalent bruton tyrosine kinase inhibitor; CI = confidence interval.</div>

Advances in Hematology

fig3

Figure 3

Figure 3: Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study 

Figure 3 | Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study 